Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Faran Pharmed is a prominent Iranian pharmaceutical company and a core subsidiary of the Golrang Pharmaceutical Group. Established in 1992, the company specializes in the development and large-scale production of both Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Faran Pharmed is a market leader in the production of maintenance therapy medications for opioid addiction, including methadone and buprenorphine. The company operates advanced manufacturing facilities in Tuyserkan, Hamedan, which are designed to meet international GMP standards. Its diverse portfolio also covers critical therapeutic areas such as cardiovascular health, urology, and central nervous system disorders, supplying both domestic and regional healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Faran Pharmed.